Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00301249 · ClinicalTrials.gov registry record

The Family Investigation of Nephropathy and Diabetes Study

A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Completed
Registry status
9,031
Enrollment target

NCT00301249 is a clinical trial that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 9,031 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00301249 has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

COMPLETED
Registry status
9,031 participants
Enrollment target

Study Summary

The Family Investigation of Nephropathy and Diabetes (FIND)Study is a multi-center consortium. The charge of the consortium is to acquire sets of families with well-characterized diabetic nephropathy, establish a secure master FIND database, and perform a genome scan to identify chromosomal regions linked with diabetic nephropathy.

Trial Details

FieldValue
Enrollment Target 9,031 participants
Start Date 1999-10
Est. Completion 2006-12

What the Registry Record Tells You About NCT00301249

The ClinicalTrials.gov registry entry for NCT00301249 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9,031 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00301249 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00301249 about?

NCT00301249 is a clinical study titled "The Family Investigation of Nephropathy and Diabetes Study". The Family Investigation of Nephropathy and Diabetes (FIND)Study is a multi-center consortium. The charge of the consortium is to acquire sets of families with well-characterized diabetic nephropathy, establish a secure master FIND database, and perform a genome scan to identify chromosomal regions ...

What is the current status of trial NCT00301249?

This trial is currently completed. The enrollment target is 9,031 participants. The study started on 1999-10. Estimated completion is 2006-12.

Who is sponsoring clinical trial NCT00301249?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.